Title : Measurement of neutralizing antibodies to interferon beta in patients with multiple sclerosis.

Pub. Date : 2004 Jun

PMID : 15264110






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Treatment of multiple sclerosis (MS) with interferon beta (IFNbeta) can be associated with the development of binding antibodies (BAbs) and neutralizing antibodies (NAbs). babs interferon beta 1 Homo sapiens
2 Treatment of multiple sclerosis (MS) with interferon beta (IFNbeta) can be associated with the development of binding antibodies (BAbs) and neutralizing antibodies (NAbs). babs interferon beta 1 Homo sapiens
3 NAbs are a subset of BAbs that prevent IFNbeta from effectively binding to or activating its receptor, thereby blocking its biologic effects and inhibiting its therapeutic effects. babs interferon beta 1 Homo sapiens